[Radiation therapy of benign diseases. What's new eight years after?].
The authors present an update version of the indications for radiotherapy in the management of benign diseases. This is based on available randomized trials and recent international meetings. Validated indications remain the prevention of resected heterotopic bone ossifications, keloïds scars and pterygium and also treatment of arteriovenous malformations; the place of radiotherapy for malignant exophtalmia is more and more restricted. Randomized trials have demonstrated the efficacy of endobrachytherapy in the prevention of restenosis after angioplasty but the use of embedded stent has replaced this indication. Macular degeneration is no more an indication of radiotherapy. Quality requirements for radiotherapy are identical for benign or malignant indications.
Van Houtte
P
P
Département de radio-oncologie, institut Jules-Bordet, 121, boulevard de Waterloo, 1000 Bruxelles, Belgique. paul.vanhoutte@bordet.be
Roelandts
M
M
Devriendt
D
D
Minsat
M
M
Laharie
H
H
Kantor
G
G
D001165:Arteriovenous Malformations / Q000532:radiotherapy*; D001847:Bone Diseases / Q000532:radiotherapy*; D001918:Brachytherapy / Q000379:methods; D006801:Humans; D011786:Quality Control; D011878:Radiotherapy / Q000379:methods / Q000639:trends*